

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | response to muscle activity (GO:0014850) | 7.96231058 |
| 2 | ADP metabolic process (GO:0046031) | 6.67087838 |
| 3 | AMP metabolic process (GO:0046033) | 6.12942529 |
| 4 | muscle cell cellular homeostasis (GO:0046716) | 5.79576807 |
| 5 | regulation of oxidative phosphorylation (GO:0002082) | 5.79049768 |
| 6 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 5.57302211 |
| 7 | * response to zinc ion (GO:0010043) | 5.47877378 |
| 8 | nucleoside diphosphate biosynthetic process (GO:0009133) | 5.31729160 |
| 9 | coenzyme catabolic process (GO:0009109) | 4.95495229 |
| 10 | activation of protein kinase B activity (GO:0032148) | 4.90739549 |
| 11 | regulation of oxidative stress-induced neuron death (GO:1903203) | 4.86047877 |
| 12 | myofibril assembly (GO:0030239) | 4.82120732 |
| 13 | positive regulation of catecholamine secretion (GO:0033605) | 4.65752800 |
| 14 | nucleobase-containing small molecule interconversion (GO:0015949) | 4.48562760 |
| 15 | actin-myosin filament sliding (GO:0033275) | 4.38134938 |
| 16 | muscle filament sliding (GO:0030049) | 4.38134938 |
| 17 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 4.20725629 |
| 18 | negative regulation of response to reactive oxygen species (GO:1901032) | 4.20431635 |
| 19 | purine nucleoside diphosphate metabolic process (GO:0009135) | 4.13951899 |
| 20 | purine ribonucleoside diphosphate metabolic process (GO:0009179) | 4.13951899 |
| 21 | fructose metabolic process (GO:0006000) | 4.08438167 |
| 22 | * response to cadmium ion (GO:0046686) | 4.02469018 |
| 23 | negative regulation of lipase activity (GO:0060192) | 4.01713994 |
| 24 | regulation of skeletal muscle contraction (GO:0014819) | 3.73857787 |
| 25 | actin-mediated cell contraction (GO:0070252) | 3.70909056 |
| 26 | regulation of cellular respiration (GO:0043457) | 3.64112345 |
| 27 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 3.53027442 |
| 28 | cofactor catabolic process (GO:0051187) | 3.52319680 |
| 29 | xenobiotic catabolic process (GO:0042178) | 3.50840864 |
| 30 | sarcomere organization (GO:0045214) | 3.43767124 |
| 31 | response to mercury ion (GO:0046689) | 3.38303445 |
| 32 | regulation of protein sumoylation (GO:0033233) | 3.34380861 |
| 33 | cytolysis (GO:0019835) | 3.29500227 |
| 34 | triglyceride homeostasis (GO:0070328) | 3.28137310 |
| 35 | acylglycerol homeostasis (GO:0055090) | 3.28137310 |
| 36 | skeletal muscle fiber development (GO:0048741) | 3.26907108 |
| 37 | nucleotide-sugar biosynthetic process (GO:0009226) | 3.26756573 |
| 38 | ribonucleoside diphosphate metabolic process (GO:0009185) | 3.19135288 |
| 39 | nucleoside diphosphate phosphorylation (GO:0006165) | 3.18109758 |
| 40 | myotube cell development (GO:0014904) | 3.11019994 |
| 41 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.10213912 |
| 42 | regulation of relaxation of muscle (GO:1901077) | 3.07908441 |
| 43 | omega-hydroxylase P450 pathway (GO:0097267) | 3.06610864 |
| 44 | * cellular response to metal ion (GO:0071248) | 3.04632219 |
| 45 | positive regulation of wound healing (GO:0090303) | 3.04186530 |
| 46 | regulation of myoblast differentiation (GO:0045661) | 2.99065513 |
| 47 | regulation of autophagic vacuole assembly (GO:2000785) | 2.96731954 |
| 48 | TOR signaling (GO:0031929) | 2.92353462 |
| 49 | positive regulation of release of sequestered calcium ion into cytosol (GO:0051281) | 2.92114819 |
| 50 | skeletal muscle contraction (GO:0003009) | 2.87855992 |
| 51 | positive regulation of protein kinase C signaling (GO:0090037) | 2.86413626 |
| 52 | response to activity (GO:0014823) | 2.83815072 |
| 53 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 2.83563090 |
| 54 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.78955553 |
| 55 | gluconeogenesis (GO:0006094) | 2.77604690 |
| 56 | mitochondrion morphogenesis (GO:0070584) | 2.77380013 |
| 57 | cellular zinc ion homeostasis (GO:0006882) | 2.73833832 |
| 58 | hexose biosynthetic process (GO:0019319) | 2.73813037 |
| 59 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.73360700 |
| 60 | L-phenylalanine metabolic process (GO:0006558) | 2.73360700 |
| 61 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.72445133 |
| 62 | L-phenylalanine catabolic process (GO:0006559) | 2.72445133 |
| 63 | glycogen metabolic process (GO:0005977) | 2.72213747 |
| 64 | mitochondrion degradation (GO:0000422) | 2.72132866 |
| 65 | cellular response to arsenic-containing substance (GO:0071243) | 2.71050235 |
| 66 | response to salt stress (GO:0009651) | 2.68728626 |
| 67 | * cellular response to inorganic substance (GO:0071241) | 2.67764853 |
| 68 | negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176) | 2.67598598 |
| 69 | cellular glucan metabolic process (GO:0006073) | 2.66660685 |
| 70 | glucan metabolic process (GO:0044042) | 2.66660685 |
| 71 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 2.65811434 |
| 72 | acute-phase response (GO:0006953) | 2.65011521 |
| 73 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.64032775 |
| 74 | glutathione derivative metabolic process (GO:1901685) | 2.63746409 |
| 75 | glutathione derivative biosynthetic process (GO:1901687) | 2.63746409 |
| 76 | cellular response to toxic substance (GO:0097237) | 2.59930327 |
| 77 | actin filament-based movement (GO:0030048) | 2.56135701 |
| 78 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.55211745 |
| 79 | * response to transition metal nanoparticle (GO:1990267) | 2.51568430 |
| 80 | epoxygenase P450 pathway (GO:0019373) | 2.51054804 |
| 81 | proteasome assembly (GO:0043248) | 2.51047101 |
| 82 | regulation of lipoprotein lipase activity (GO:0051004) | 2.49999701 |
| 83 | glycogen catabolic process (GO:0005980) | 2.48963752 |
| 84 | endocrine hormone secretion (GO:0060986) | 2.47112769 |
| 85 | muscle fiber development (GO:0048747) | 2.45631536 |
| 86 | monosaccharide biosynthetic process (GO:0046364) | 2.44549380 |
| 87 | L-ascorbic acid metabolic process (GO:0019852) | 2.43347782 |
| 88 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.42388663 |
| 89 | positive regulation of p38MAPK cascade (GO:1900745) | 2.41037078 |
| 90 | negative regulation of reactive oxygen species metabolic process (GO:2000378) | 2.39648602 |
| 91 | response to ischemia (GO:0002931) | 2.39576804 |
| 92 | copper ion transport (GO:0006825) | 2.39264091 |
| 93 | regulation of protein kinase C signaling (GO:0090036) | 2.39069322 |
| 94 | negative regulation of homotypic cell-cell adhesion (GO:0034111) | 2.38169344 |
| 95 | lactate metabolic process (GO:0006089) | 2.36282757 |
| 96 | regulation of phospholipase A2 activity (GO:0032429) | 2.35917001 |
| 97 | nitric oxide mediated signal transduction (GO:0007263) | 2.35556205 |
| 98 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.33711301 |
| 99 | * cellular response to zinc ion (GO:0071294) | 15.8073963 |
| 100 | * cellular response to cadmium ion (GO:0071276) | 10.9456453 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 6.07473901 |
| 2 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 5.89888118 |
| 3 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.65255360 |
| 4 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 4.33031605 |
| 5 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.95756035 |
| 6 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.48650170 |
| 7 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 3.47324753 |
| 8 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.83892232 |
| 9 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 2.79517985 |
| 10 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 2.76346998 |
| 11 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.57486590 |
| 12 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 2.51905455 |
| 13 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.41096326 |
| 14 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.21665397 |
| 15 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.19452588 |
| 16 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 2.09639374 |
| 17 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 2.08035667 |
| 18 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 2.05117791 |
| 19 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.94421829 |
| 20 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 1.93759287 |
| 21 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.92574885 |
| 22 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.75215882 |
| 23 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.70909117 |
| 24 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.61139005 |
| 25 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.60605239 |
| 26 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.57075397 |
| 27 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.57075397 |
| 28 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.56079080 |
| 29 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.52024145 |
| 30 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.49113947 |
| 31 | CJUN_26792858_Chip-Seq_BT549_Human | 1.45212168 |
| 32 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.43295261 |
| 33 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.40112845 |
| 34 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.39649599 |
| 35 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.36677583 |
| 36 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 1.29932926 |
| 37 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.29124383 |
| 38 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.29124383 |
| 39 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.29124383 |
| 40 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.28179736 |
| 41 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.26653437 |
| 42 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.26406950 |
| 43 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.26367485 |
| 44 | * SOX2_20726797_ChIP-Seq_SW620_Human | 1.24807145 |
| 45 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.21646284 |
| 46 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.21467409 |
| 47 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.21000383 |
| 48 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.18613794 |
| 49 | * ATF3_27146783_Chip-Seq_COLON_Human | 1.09371521 |
| 50 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.09154647 |
| 51 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.08983986 |
| 52 | HTT_18923047_ChIP-ChIP_STHdh_Human | 1.05806619 |
| 53 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.03952191 |
| 54 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.03483102 |
| 55 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.01785292 |
| 56 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.01785292 |
| 57 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.00139434 |
| 58 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.99132556 |
| 59 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.95865296 |
| 60 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.95054876 |
| 61 | SOX3_22085726_ChIP-Seq_MUSCLE_Mouse | 0.94368017 |
| 62 | DCP1A_22483619_ChIP-Seq_HELA_Human | 0.93235709 |
| 63 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.92579471 |
| 64 | CBP_21632823_ChIP-Seq_H3396_Human | 0.90814023 |
| 65 | GRHL2_25758223_ChIP-Seq_PLACENTA_Mouse | 0.89856731 |
| 66 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.89247707 |
| 67 | MYC_19829295_ChIP-Seq_ESCs_Human | 0.86971096 |
| 68 | VDR_22108803_ChIP-Seq_LS180_Human | 0.86537378 |
| 69 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.85293568 |
| 70 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 0.85260866 |
| 71 | FOXH1_21741376_ChIP-Seq_EPCs_Human | 0.81806090 |
| 72 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.81694532 |
| 73 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.81063291 |
| 74 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.79896239 |
| 75 | STAT1_20625510_ChIP-Seq_HELA_Human | 0.79737228 |
| 76 | GATA3_24758297_ChIP-Seq_MCF-7_Human | 0.78668565 |
| 77 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 0.77380828 |
| 78 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.76527085 |
| 79 | RXR_22108803_ChIP-Seq_LS180_Human | 0.76093163 |
| 80 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.75954750 |
| 81 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.75393320 |
| 82 | ELF5_23300383_ChIP-Seq_T47D_Human | 0.75135105 |
| 83 | CEBPA_26348894_ChIP-Seq_LIVER_Mouse | 0.73374229 |
| 84 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 0.73349483 |
| 85 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.72343965 |
| 86 | CDX2_22108803_ChIP-Seq_LS180_Human | 0.71881991 |
| 87 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.71776007 |
| 88 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 0.71296323 |
| 89 | BMI1_19503595_ChIP-Seq_MEFsC_Mouse | 0.71101126 |
| 90 | BRD4_25478319_ChIP-Seq_HGPS_Human | 0.70487808 |
| 91 | * NANOG_20526341_ChIP-Seq_ESCs_Human | 0.70063126 |
| 92 | CEBPB_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.69517027 |
| 93 | CTCF_18555785_ChIP-Seq_MESCs_Mouse | 0.68732903 |
| 94 | RAC3_21632823_ChIP-Seq_H3396_Human | 0.68423422 |
| 95 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.67844195 |
| 96 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.67824799 |
| 97 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 0.66656211 |
| 98 | LDB1_21186366_ChIP-Seq_BM-HSCs_Mouse | 0.66197787 |
| 99 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 0.66169926 |
| 100 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.66003356 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003806_abnormal_nucleotide_metabolis | 6.83659731 |
| 2 | MP0000749_muscle_degeneration | 5.62004486 |
| 3 | MP0002837_dystrophic_cardiac_calcinosis | 5.37028030 |
| 4 | MP0003011_delayed_dark_adaptation | 5.01783355 |
| 5 | MP0003950_abnormal_plasma_membrane | 3.53728216 |
| 6 | MP0009840_abnormal_foam_cell | 2.88399509 |
| 7 | MP0004084_abnormal_cardiac_muscle | 2.76724854 |
| 8 | MP0006036_abnormal_mitochondrial_physio | 2.70141749 |
| 9 | MP0005330_cardiomyopathy | 2.50740641 |
| 10 | MP0004510_myositis | 2.49185053 |
| 11 | MP0005360_urolithiasis | 2.47970095 |
| 12 | MP0010368_abnormal_lymphatic_system | 2.29696875 |
| 13 | MP0003646_muscle_fatigue | 2.22062022 |
| 14 | MP0002269_muscular_atrophy | 2.21641482 |
| 15 | MP0005451_abnormal_body_composition | 2.19379558 |
| 16 | MP0010234_abnormal_vibrissa_follicle | 2.19348949 |
| 17 | MP0009780_abnormal_chondrocyte_physiolo | 2.13928805 |
| 18 | MP0004036_abnormal_muscle_relaxation | 2.09789588 |
| 19 | MP0000343_altered_response_to | 2.08844903 |
| 20 | MP0004233_abnormal_muscle_weight | 2.04294954 |
| 21 | MP0001879_abnormal_lymphatic_vessel | 1.99716230 |
| 22 | MP0004215_abnormal_myocardial_fiber | 1.97773282 |
| 23 | MP0002254_reproductive_system_inflammat | 1.96991887 |
| 24 | MP0002139_abnormal_hepatobiliary_system | 1.93559750 |
| 25 | MP0003186_abnormal_redox_activity | 1.87349703 |
| 26 | MP0004019_abnormal_vitamin_homeostasis | 1.78386350 |
| 27 | MP0005670_abnormal_white_adipose | 1.72699298 |
| 28 | MP0005666_abnormal_adipose_tissue | 1.68622688 |
| 29 | MP0003195_calcinosis | 1.63408249 |
| 30 | MP0002108_abnormal_muscle_morphology | 1.59675976 |
| 31 | MP0002295_abnormal_pulmonary_circulatio | 1.57876841 |
| 32 | MP0000759_abnormal_skeletal_muscle | 1.55416363 |
| 33 | MP0004087_abnormal_muscle_fiber | 1.47915391 |
| 34 | MP0009697_abnormal_copulation | 1.44998209 |
| 35 | MP0005620_abnormal_muscle_contractility | 1.44092694 |
| 36 | MP0000750_abnormal_muscle_regeneration | 1.32916281 |
| 37 | MP0010329_abnormal_lipoprotein_level | 1.31575897 |
| 38 | MP0008004_abnormal_stomach_pH | 1.29113202 |
| 39 | MP0004272_abnormal_basement_membrane | 1.28933837 |
| 40 | MP0000747_muscle_weakness | 1.28024927 |
| 41 | MP0000751_myopathy | 1.25465271 |
| 42 | MP0008875_abnormal_xenobiotic_pharmacok | 1.25265146 |
| 43 | MP0002972_abnormal_cardiac_muscle | 1.24458312 |
| 44 | MP0005266_abnormal_metabolism | 1.24179587 |
| 45 | MP0008775_abnormal_heart_ventricle | 1.22861357 |
| 46 | MP0005375_adipose_tissue_phenotype | 1.19346560 |
| 47 | MP0005058_abnormal_lysosome_morphology | 1.17862386 |
| 48 | MP0005166_decreased_susceptibility_to | 1.16878201 |
| 49 | MP0005410_abnormal_fertilization | 1.16358707 |
| 50 | MP0010030_abnormal_orbit_morphology | 1.15567969 |
| 51 | MP0004484_altered_response_of | 1.14637536 |
| 52 | MP0001661_extended_life_span | 1.10505493 |
| 53 | MP0005332_abnormal_amino_acid | 1.06024534 |
| 54 | MP0005369_muscle_phenotype | 1.00063692 |
| 55 | MP0005275_abnormal_skin_tensile | 0.96494403 |
| 56 | MP0006138_congestive_heart_failure | 0.96230188 |
| 57 | MP0001984_abnormal_olfaction | 0.95574293 |
| 58 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.92766022 |
| 59 | MP0008438_abnormal_cutaneous_collagen | 0.92082279 |
| 60 | MP0002138_abnormal_hepatobiliary_system | 0.86545305 |
| 61 | MP0002332_abnormal_exercise_endurance | 0.86209672 |
| 62 | MP0003279_aneurysm | 0.85368137 |
| 63 | MP0001849_ear_inflammation | 0.83032228 |
| 64 | MP0002876_abnormal_thyroid_physiology | 0.81876423 |
| 65 | MP0000762_abnormal_tongue_morphology | 0.81396960 |
| 66 | MP0002118_abnormal_lipid_homeostasis | 0.80787371 |
| 67 | MP0002971_abnormal_brown_adipose | 0.80537070 |
| 68 | MP0002132_abnormal_respiratory_system | 0.80262840 |
| 69 | MP0001299_abnormal_eye_distance/ | 0.79566082 |
| 70 | MP0001501_abnormal_sleep_pattern | 0.78917960 |
| 71 | MP0005376_homeostasis/metabolism_phenot | 0.78038699 |
| 72 | MP0000013_abnormal_adipose_tissue | 0.77997819 |
| 73 | MP0008260_abnormal_autophagy | 0.77919089 |
| 74 | MP0003075_altered_response_to | 0.77518910 |
| 75 | MP0002106_abnormal_muscle_physiology | 0.76571258 |
| 76 | MP0002160_abnormal_reproductive_system | 0.76358775 |
| 77 | MP0001905_abnormal_dopamine_level | 0.76030930 |
| 78 | MP0001853_heart_inflammation | 0.74411903 |
| 79 | MP0002078_abnormal_glucose_homeostasis | 0.72606023 |
| 80 | MP0003315_abnormal_perineum_morphology | 0.72516247 |
| 81 | MP0005334_abnormal_fat_pad | 0.72237120 |
| 82 | MP0001764_abnormal_homeostasis | 0.72020868 |
| 83 | MP0001756_abnormal_urination | 0.71690708 |
| 84 | MP0005023_abnormal_wound_healing | 0.70865354 |
| 85 | MP0002796_impaired_skin_barrier | 0.70791471 |
| 86 | MP0004145_abnormal_muscle_electrophysio | 0.69854322 |
| 87 | MP0005385_cardiovascular_system_phenoty | 0.68540237 |
| 88 | MP0001544_abnormal_cardiovascular_syste | 0.68540237 |
| 89 | MP0005319_abnormal_enzyme/_coenzyme | 0.68331690 |
| 90 | MP0003453_abnormal_keratinocyte_physiol | 0.67273487 |
| 91 | MP0003718_maternal_effect | 0.66274654 |
| 92 | MP0003868_abnormal_feces_composition | 0.65194423 |
| 93 | MP0006072_abnormal_retinal_apoptosis | 0.64158522 |
| 94 | MP0005448_abnormal_energy_balance | 0.63077767 |
| 95 | MP0005452_abnormal_adipose_tissue | 0.62969712 |
| 96 | MP0005595_abnormal_vascular_smooth | 0.62889451 |
| 97 | MP0004043_abnormal_pH_regulation | 0.60794636 |
| 98 | MP0005365_abnormal_bile_salt | 0.60485343 |
| 99 | MP0005165_increased_susceptibility_to | 0.58356640 |
| 100 | MP0001502_abnormal_circadian_rhythm | 0.56870498 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 5.82354412 |
| 2 | Hyporeflexia of lower limbs (HP:0002600) | 5.57453969 |
| 3 | Muscle fiber inclusion bodies (HP:0100299) | 5.54602753 |
| 4 | Exercise-induced myalgia (HP:0003738) | 5.26349082 |
| 5 | Abnormality of the calf musculature (HP:0001430) | 5.18747414 |
| 6 | Scapular winging (HP:0003691) | 5.17742020 |
| 7 | Exercise-induced muscle cramps (HP:0003710) | 5.11226176 |
| 8 | EMG: myopathic abnormalities (HP:0003458) | 4.95403118 |
| 9 | Right ventricular cardiomyopathy (HP:0011663) | 4.74969094 |
| 10 | Rimmed vacuoles (HP:0003805) | 4.60728949 |
| 11 | Clumsiness (HP:0002312) | 4.47103992 |
| 12 | Abnormality of the shoulder girdle musculature (HP:0001435) | 4.40062723 |
| 13 | Muscle fiber splitting (HP:0003555) | 4.25872588 |
| 14 | Neck muscle weakness (HP:0000467) | 4.09497835 |
| 15 | Calf muscle hypertrophy (HP:0008981) | 4.03596227 |
| 16 | Myoglobinuria (HP:0002913) | 3.90956668 |
| 17 | Rhabdomyolysis (HP:0003201) | 3.83699265 |
| 18 | Muscle hypertrophy of the lower extremities (HP:0008968) | 3.82232431 |
| 19 | Proximal amyotrophy (HP:0007126) | 3.78556866 |
| 20 | Limb-girdle muscle atrophy (HP:0003797) | 3.70922383 |
| 21 | Resting tremor (HP:0002322) | 3.65260689 |
| 22 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 3.59250128 |
| 23 | Myopathic facies (HP:0002058) | 3.46326234 |
| 24 | Nemaline bodies (HP:0003798) | 3.43734237 |
| 25 | Eosinophilia (HP:0001880) | 3.29705894 |
| 26 | Increased variability in muscle fiber diameter (HP:0003557) | 3.14173986 |
| 27 | Bulbar palsy (HP:0001283) | 3.11527283 |
| 28 | Abnormality of the intrinsic pathway (HP:0010989) | 3.06642998 |
| 29 | Axonal loss (HP:0003447) | 3.05435389 |
| 30 | Type 1 muscle fiber predominance (HP:0003803) | 3.00767510 |
| 31 | Reduced antithrombin III activity (HP:0001976) | 2.99707548 |
| 32 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.98272277 |
| 33 | Muscle stiffness (HP:0003552) | 2.97744975 |
| 34 | Diaphragmatic weakness (HP:0009113) | 2.95953203 |
| 35 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.90162495 |
| 36 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.90162495 |
| 37 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.89801471 |
| 38 | Spinal rigidity (HP:0003306) | 2.80429815 |
| 39 | Distal arthrogryposis (HP:0005684) | 2.78450860 |
| 40 | Foot dorsiflexor weakness (HP:0009027) | 2.76671778 |
| 41 | Frequent falls (HP:0002359) | 2.70812476 |
| 42 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 2.67439017 |
| 43 | Abnormality of the foot musculature (HP:0001436) | 2.67100134 |
| 44 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.59961226 |
| 45 | Prolonged partial thromboplastin time (HP:0003645) | 2.56904506 |
| 46 | Systemic lupus erythematosus (HP:0002725) | 2.56579105 |
| 47 | Acute necrotizing encephalopathy (HP:0006965) | 2.51691111 |
| 48 | Progressive macrocephaly (HP:0004481) | 2.50256505 |
| 49 | Difficulty running (HP:0009046) | 2.48320238 |
| 50 | Granulocytopenia (HP:0001913) | 2.45484774 |
| 51 | Complement deficiency (HP:0004431) | 2.44070054 |
| 52 | Muscular dystrophy (HP:0003560) | 2.44018789 |
| 53 | Hypoglycemic coma (HP:0001325) | 2.37770295 |
| 54 | Weak cry (HP:0001612) | 2.34619811 |
| 55 | Sudden death (HP:0001699) | 2.33307964 |
| 56 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.32491364 |
| 57 | Popliteal pterygium (HP:0009756) | 2.27800645 |
| 58 | Abnormality of placental membranes (HP:0011409) | 2.25661565 |
| 59 | Amniotic constriction ring (HP:0009775) | 2.25661565 |
| 60 | Difficulty walking (HP:0002355) | 2.25531920 |
| 61 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.20829477 |
| 62 | Mitochondrial inheritance (HP:0001427) | 2.20045572 |
| 63 | Malignant hyperthermia (HP:0002047) | 2.19801871 |
| 64 | Hypoglycemic seizures (HP:0002173) | 2.19250746 |
| 65 | Symptomatic seizures (HP:0011145) | 2.16816595 |
| 66 | Acute encephalopathy (HP:0006846) | 2.15631407 |
| 67 | Exercise intolerance (HP:0003546) | 2.13176258 |
| 68 | Nonprogressive disorder (HP:0003680) | 2.09755382 |
| 69 | Generalized amyotrophy (HP:0003700) | 2.07838888 |
| 70 | Abnormal gallbladder physiology (HP:0012438) | 2.06091590 |
| 71 | Cholecystitis (HP:0001082) | 2.06091590 |
| 72 | Ketosis (HP:0001946) | 2.05582111 |
| 73 | Hepatic necrosis (HP:0002605) | 2.02973954 |
| 74 | Dilated cardiomyopathy (HP:0001644) | 2.02802287 |
| 75 | Difficulty climbing stairs (HP:0003551) | 2.01958598 |
| 76 | Xanthomatosis (HP:0000991) | 1.99749526 |
| 77 | Hepatocellular necrosis (HP:0001404) | 1.99452783 |
| 78 | Increased serum pyruvate (HP:0003542) | 1.98913028 |
| 79 | Back pain (HP:0003418) | 1.97107279 |
| 80 | Ventricular fibrillation (HP:0001663) | 1.97091465 |
| 81 | Increased muscle lipid content (HP:0009058) | 1.96620774 |
| 82 | Insulin-resistant diabetes mellitus (HP:0000831) | 1.94976992 |
| 83 | Azoospermia (HP:0000027) | 1.94015496 |
| 84 | Lipid accumulation in hepatocytes (HP:0006561) | 1.91685175 |
| 85 | Areflexia of lower limbs (HP:0002522) | 1.91146002 |
| 86 | Abnormality of complement system (HP:0005339) | 1.90963583 |
| 87 | Generalized aminoaciduria (HP:0002909) | 1.86598791 |
| 88 | Cerebral hypomyelination (HP:0006808) | 1.84962462 |
| 89 | Abnormality of eosinophils (HP:0001879) | 1.84623638 |
| 90 | Aplasia cutis congenita (HP:0001057) | 1.84534113 |
| 91 | Abnormality of glycolysis (HP:0004366) | 1.84050572 |
| 92 | Conjunctival hamartoma (HP:0100780) | 1.81656883 |
| 93 | Hyperlipoproteinemia (HP:0010980) | 1.81551893 |
| 94 | Increased CSF lactate (HP:0002490) | 1.80889177 |
| 95 | Lipoatrophy (HP:0100578) | 1.77668645 |
| 96 | Bundle branch block (HP:0011710) | 1.77115862 |
| 97 | Abnormality of the neuromuscular junction (HP:0003398) | 1.76420395 |
| 98 | Fatigable weakness (HP:0003473) | 1.76420395 |
| 99 | Recurrent corneal erosions (HP:0000495) | 1.76067978 |
| 100 | Cerebral edema (HP:0002181) | 1.72582280 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PINK1 | 8.64249406 |
| 2 | OBSCN | 5.90099700 |
| 3 | ARAF | 3.39535609 |
| 4 | NME2 | 2.95229304 |
| 5 | PHKG1 | 2.78854439 |
| 6 | PHKG2 | 2.78854439 |
| 7 | MARK3 | 2.63465882 |
| 8 | MAP3K9 | 2.62734851 |
| 9 | MAP3K3 | 2.53894360 |
| 10 | MAP3K13 | 2.45019993 |
| 11 | STK24 | 2.44353243 |
| 12 | LATS2 | 2.26871566 |
| 13 | MAP4K2 | 1.84956602 |
| 14 | MUSK | 1.80074879 |
| 15 | MAP3K1 | 1.70979639 |
| 16 | EIF2AK3 | 1.65988111 |
| 17 | MOS | 1.59648564 |
| 18 | PBK | 1.58073082 |
| 19 | PDK2 | 1.54726045 |
| 20 | FRK | 1.43721244 |
| 21 | MST4 | 1.33274658 |
| 22 | STK38L | 1.24899319 |
| 23 | ABL2 | 1.23566742 |
| 24 | GRK1 | 1.23298002 |
| 25 | LATS1 | 1.20019648 |
| 26 | ILK | 1.16111375 |
| 27 | MYLK | 1.14079888 |
| 28 | DDR2 | 1.06944213 |
| 29 | MAPKAPK3 | 1.06392895 |
| 30 | MAPK12 | 1.04715444 |
| 31 | AKT2 | 0.98031732 |
| 32 | STK16 | 0.91728280 |
| 33 | BRAF | 0.90219813 |
| 34 | PRKG2 | 0.88753358 |
| 35 | NME1 | 0.85333731 |
| 36 | TESK1 | 0.85324556 |
| 37 | ZAK | 0.81864166 |
| 38 | BMPR1B | 0.79311624 |
| 39 | SGK494 | 0.77749460 |
| 40 | SGK223 | 0.77749460 |
| 41 | MAP3K12 | 0.75153557 |
| 42 | NLK | 0.74178078 |
| 43 | TIE1 | 0.70343370 |
| 44 | IRAK3 | 0.68390696 |
| 45 | CLK1 | 0.67141237 |
| 46 | ROCK2 | 0.66619805 |
| 47 | STK3 | 0.66249565 |
| 48 | CSNK1G1 | 0.63875704 |
| 49 | CSNK1G3 | 0.61073744 |
| 50 | SGK2 | 0.60340113 |
| 51 | SGK3 | 0.60173907 |
| 52 | TTN | 0.59911738 |
| 53 | ROCK1 | 0.58671472 |
| 54 | CSNK1A1L | 0.57807033 |
| 55 | KSR2 | 0.57060227 |
| 56 | TRPM7 | 0.54807118 |
| 57 | BUB1 | 0.50484316 |
| 58 | FGFR2 | 0.46080524 |
| 59 | CAMK2G | 0.45206192 |
| 60 | PRKAA2 | 0.44799300 |
| 61 | MAP2K7 | 0.43416205 |
| 62 | CSNK1G2 | 0.42097205 |
| 63 | LIMK1 | 0.42028003 |
| 64 | TLK1 | 0.41502694 |
| 65 | VRK2 | 0.41457505 |
| 66 | RAF1 | 0.41298865 |
| 67 | NEK1 | 0.41261539 |
| 68 | PRKG1 | 0.40951756 |
| 69 | TGFBR1 | 0.40761484 |
| 70 | GSK3A | 0.37919702 |
| 71 | PIK3CG | 0.36605156 |
| 72 | GRK5 | 0.35564226 |
| 73 | PAK1 | 0.35312766 |
| 74 | BCKDK | 0.34445731 |
| 75 | ADRBK2 | 0.34384440 |
| 76 | ERBB4 | 0.33140875 |
| 77 | CAMK2D | 0.32713528 |
| 78 | STK4 | 0.31004881 |
| 79 | EIF2AK1 | 0.29990743 |
| 80 | IRAK2 | 0.29265403 |
| 81 | PRKCQ | 0.28915271 |
| 82 | RPS6KB1 | 0.27914297 |
| 83 | PDPK1 | 0.25868982 |
| 84 | AKT3 | 0.24451286 |
| 85 | PTK2 | 0.23866624 |
| 86 | PIM2 | 0.23184954 |
| 87 | LMTK2 | 0.22419713 |
| 88 | DAPK3 | 0.21609393 |
| 89 | EPHB1 | 0.21005387 |
| 90 | MAP2K6 | 0.19905055 |
| 91 | PRKACA | 0.19247192 |
| 92 | CSNK1A1 | 0.18486043 |
| 93 | CSNK2A2 | 0.18270204 |
| 94 | FGFR1 | 0.18204553 |
| 95 | STK38 | 0.18094397 |
| 96 | TGFBR2 | 0.18024794 |
| 97 | PKN1 | 0.17969078 |
| 98 | NEK6 | 0.17760148 |
| 99 | MAP3K7 | 0.16771699 |
| 100 | CSNK2A1 | 0.15735929 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | * Mineral absorption_Homo sapiens_hsa04978 | 4.44671140 |
| 2 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.42529622 |
| 3 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.32786343 |
| 4 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.32005521 |
| 5 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.26310982 |
| 6 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 2.25920639 |
| 7 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.24570385 |
| 8 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 2.22036801 |
| 9 | Circadian rhythm_Homo sapiens_hsa04710 | 2.19821085 |
| 10 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.11918256 |
| 11 | Parkinsons disease_Homo sapiens_hsa05012 | 1.96996045 |
| 12 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.93786656 |
| 13 | Proteasome_Homo sapiens_hsa03050 | 1.90533143 |
| 14 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.89658977 |
| 15 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.86382840 |
| 16 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.79319064 |
| 17 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.78817737 |
| 18 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.77012621 |
| 19 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.76481259 |
| 20 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.71457896 |
| 21 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.71261469 |
| 22 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.70568349 |
| 23 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.68796829 |
| 24 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.63158459 |
| 25 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.61152209 |
| 26 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.60174498 |
| 27 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.58758587 |
| 28 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.54603586 |
| 29 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.54354151 |
| 30 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.49553337 |
| 31 | Retinol metabolism_Homo sapiens_hsa00830 | 1.45862399 |
| 32 | Histidine metabolism_Homo sapiens_hsa00340 | 1.44316359 |
| 33 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.39838101 |
| 34 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.39114576 |
| 35 | Alzheimers disease_Homo sapiens_hsa05010 | 1.37715615 |
| 36 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.36978655 |
| 37 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.31038194 |
| 38 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.29658232 |
| 39 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.28933641 |
| 40 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.24907031 |
| 41 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.22820544 |
| 42 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.21438492 |
| 43 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.20646485 |
| 44 | Carbon metabolism_Homo sapiens_hsa01200 | 1.20280764 |
| 45 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.18872083 |
| 46 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.16153257 |
| 47 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.15051941 |
| 48 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.08820213 |
| 49 | Protein export_Homo sapiens_hsa03060 | 1.07688178 |
| 50 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.04777493 |
| 51 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.04487578 |
| 52 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.00611479 |
| 53 | Peroxisome_Homo sapiens_hsa04146 | 0.98514685 |
| 54 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.96525589 |
| 55 | Sulfur relay system_Homo sapiens_hsa04122 | 0.94349467 |
| 56 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.94134293 |
| 57 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.92870572 |
| 58 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.92829172 |
| 59 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.92624530 |
| 60 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.92583581 |
| 61 | Huntingtons disease_Homo sapiens_hsa05016 | 0.91694120 |
| 62 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.90475631 |
| 63 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.89248885 |
| 64 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.89006206 |
| 65 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.82319642 |
| 66 | Metabolic pathways_Homo sapiens_hsa01100 | 0.72581134 |
| 67 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.72332197 |
| 68 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.71432686 |
| 69 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.71143163 |
| 70 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.67072515 |
| 71 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.65829412 |
| 72 | Galactose metabolism_Homo sapiens_hsa00052 | 0.65006674 |
| 73 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.63606609 |
| 74 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.63477458 |
| 75 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.62921864 |
| 76 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.60490122 |
| 77 | Ribosome_Homo sapiens_hsa03010 | 0.59785211 |
| 78 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.55219625 |
| 79 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.53147677 |
| 80 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.52545948 |
| 81 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.52029991 |
| 82 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.51825974 |
| 83 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.49962059 |
| 84 | RNA polymerase_Homo sapiens_hsa03020 | 0.45622294 |
| 85 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.44815282 |
| 86 | Purine metabolism_Homo sapiens_hsa00230 | 0.43509103 |
| 87 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.43351454 |
| 88 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.40745723 |
| 89 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.40323930 |
| 90 | Prion diseases_Homo sapiens_hsa05020 | 0.40052207 |
| 91 | Bile secretion_Homo sapiens_hsa04976 | 0.36104092 |
| 92 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.33172027 |
| 93 | Insulin resistance_Homo sapiens_hsa04931 | 0.33138999 |
| 94 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.31388820 |
| 95 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.29331109 |
| 96 | Phototransduction_Homo sapiens_hsa04744 | 0.29050906 |
| 97 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.28302986 |
| 98 | Renin secretion_Homo sapiens_hsa04924 | 0.25771355 |
| 99 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.24883580 |
| 100 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.23985188 |

